Trial Search Results

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

VA Office of Research and Development

Collaborator: Northeastern University

Stanford Investigator(s):


  • Behavioral: Technology-assisted care transition intervention
  • Behavioral: Active attention control




Inclusion Criteria:

   - Veterans

   - Diagnosis of chronic heart failure or chronic obstructive pulmonary disease

   - Admission to a general medical service

   - Able and willing to engage with touchscreen technology

   - Have a text-enabled cellular phone to receive the post-discharge text messages

Exclusion Criteria:

   - Not Veterans

   - Not diagnosed of chronic heart failure or chronic obstructive pulmonary disease

   - Not admitted to a general medical service

   - Not capable of using touchscreen technology

   - Do not have a text-enabled cellular phone

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Paul Heidenreich, MD
Not Recruiting